Search Result "hyperkalemia"
Boosting the Limited Use of Mineralocorticoid Receptor Antagonists Through New Agents for Hyperkalemia
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 4 Year: 2018 Page: 5542-5547
Author(s): Vasilios G. Athyros,Alexandros G. Sachinidis,Ioanna Zografou,Elisavet Simoulidou,Alexia Piperidou,Nikiforos Stavropoulos,Asterios Karagiannis
The Risks and Benefits of Therapy with Aldosterone Receptor Antagonist Therapy
Journal: Current Drug Safety
Volume: 2 Issue: 1 Year: 2007 Page: 71-77
Author(s): Domenic A. Sica
A Comparison of Adverse Drug Reactions Between High- and Standard- Dose Trimethoprim-Sulfamethoxazole in the Ambulatory Setting
Journal: Current Drug Safety
Volume: 8 Issue: 2 Year: 2013 Page: 114-119
Author(s): Ann T. Nguyen, Chris A. Gentry, Rona Z. Furrh
Adverse Effects of Mineralocorticoid Receptor Antagonist Administration
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 4 Year: 2018 Page: 5537-5541
Author(s): Manolis S. Kallistratos,Andreas Pittaras,Iakovos Theodoulidis,Charris Grassos,Leonidas E. Poulimenos,Athanasios J. Manolis
Autoimmune Polyendocrine Syndrome Complicated by Pulmonary Hypertension
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 21 Issue: 3 Year: 2021 Page: 561-565
Author(s): Olga E. Disoteo,Benedetta Zampetti,Andrea Garascia,Roberto Attanasio,Renato Cozzi
Electrolyte Disturbances and QT Interval Abnormalities
Ebook: Electrocardiography (ECG)
Volume: 1 Year: 2013
Author(s): Jean-Jacques Goy,Jean-Christophe Stauffer,Jürg Schlaepfer,Pierre Christeler
Doi: 10.2174/9781608054794113010011
Resistant Hypertension in the Elderly-Second Line Treatments: Aldosterone Antagonists, Central Alpha-Agonist Agents, Alpha-Adrenergic Receptor Blockers, Direct Vasodilators, and Exogenous Nitric Oxide Donors
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 12 Issue: 3 Year: 2014 Page: 170-173
Author(s): Carlos G. Musso,Jose Alfie
Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 6 Year: 2017 Page: 599-606
Author(s): Panagiotis I. Georgianos,Vasilios Vaios,Theodoros Eleftheriadis,Pantelis Zebekakis,Vassilios Liakopoulos
COX-2 and the Kidneys
Journal: Current Pharmaceutical Design
Volume: 6 Issue: 1 Year: 2000 Page: 1737-1753
Author(s): D. O. Stichtenoth, J. C. Frolich
The Role of RAAS Inhibitors in the Prevention and Treatment of Chronic Kidney Disease in the Diabetic Population
Ebook: Diabetes: Current and Future Developments
Volume: 1 Year: 2020
Author(s): Brandon D. Barthel,Peminda K. Cabandugama,Darshan S. Khangura,L. Romayne Kurukulasuriya,James R. Sowers
Doi: 10.2174/9789811422003120010016